Black Diamond Therapeutics Cash Flow Statement 2018-2024 | BDTX

Fifteen years of historical annual cash flow statements for Black Diamond Therapeutics (BDTX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-82.44$-91.17$-125.60$-67.25$-35.26$-8.93
$0.44$0.51$0.21$0.05$0.05$0.04
$11.60$15.48$18.22$10.01$10.07$0.08
$12.04$15.99$18.43$10.07$10.12$0.12
$0$0$0$0$0$0
$0$0$0$0$0$0
$0.60$-2.23$1.57$1.07$1.45$0.26
$-0.85$-1.81$-3.26$-4.05$-2.78$-0.20
$3.69$-9.90$7.02$5.04$0.46$0.35
$-66.72$-85.08$-100.15$-52.15$-24.67$-8.45
$0.06$-0.18$-2.71$-0.14$-0.02$-0.08
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$16.28$53.55$133$-281.55$0$0
$16.28$53.55$133$-281.55$0$0
$0$0$0$0$0$0
$16.35$53.37$131$-281.69$-0.02$-0.08
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$71.93$0.18$0.73$215$0$0
$71.93$0.18$0.73$215$129$52.31
$0$0$0$0$0$0
$0$0$0$0$-1.74$0
$71.93$0.18$0.73$215$128$52.31
$21.56$-31.54$31.19$-118.89$103$43.78
$9.60$12.20$14.04$7.77$3.64$0.06
$0$0$0$0$0$0